Generex wouldn’t need anywhere near the developm
Post# of 36537
(Total Views: 270)
Posted On: 11/30/2020 8:35:26 AM
Generex wouldn’t need anywhere near the developments costs of Moderna or any Mrna company. Antigen Express (NGIO) began development of their Ii-Key peptide vaccines for infectious diseases long ago. Today they are building upon that prior work. Also, developing and later selling peptide vaccines is far less costly as is manufacturing.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼